For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not ...
One of the FDA’s potential approvals this month could break an existing monopoly in the treatment space for a rare growth ...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. | Despite the largely stagnant performance ...
Germany's Bayer said Wednesday it was confident of "significantly" containing long-running legal woes related to a weedkiller ...
Leading heart experts say the results were "somewhat surprising," and their discovery could warrant a conversation with your ...
Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.